Infectious diseases

Borrelia Line Immunoblot assays are for in vitro diagnostic (IVD) use for the qualitative detection of Borrelia (B.) burgdorferi senu lato specific IgG-respectively IgM-antibodies in human serum.

The core region is the most conserved part of different HIV strains. Antigen detection of the capsid (core) protein p24 in blood can be done earlier than detecting the presence of HIV antibodies during acute infection.

Qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.

Fujirebio Europe NV is active in the field of confirmatory testing for infectious diseases for many years. We produce recombinant antigens using Escherichia coli production systems. These materials are part of our INNOTEST or INNO-LIA products and are available for use in other diagnostic platforms.

Line immunoassay for the confirmation and discrimination of antibodies to HIV-1, HIV-1 group O and HIV-2 in human serum and plasma.

Line Immunoassay, to confirm the presence of antibodies against Treponema pallidum in human serum or plasma.

Line probe assay designed to identify hepatitis B virus genotypes A to H by the detection of type-specific sequences in the HBV polymerase gene domain B to C.

Line probe assay for simultaneous detection of hepatitis B virus wild-type motif, lamivudine, telbivudine, emtricitabine, adefovir, and entecavir resistance-associated mutations.

Enzyme immunoassay for the detection of antibodies to human hepatitis C virus (HCV) in human serum or plasma.

Objective reading and interpretation of INNO-LIA® strips for infectious diseases.

Objective reading and interpretation of the INNO-LIPA® HBV portfolio.

Objective reading and interpretation of the INNO-LiPA® strips for HPV Genotyping Extra II.

Immunoreaction cartridges set for Research Use Only (not for use in diagnostic precedures) with the LUMIPULSE G System for the quantitative detection of hepatitis B virus core-related antigen in serum or plasma.

Immunoreaction cartridges set for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative detection of hepatitis B e antigen (HBeAg) in human serum or plasma. This product is indicated as an aid in the diagnosis and monitoring of hepatitis B viral infection and for professional use only.

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System.

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 S-IgG assay on the automated LUMIPULSE G System. The assay using this control is performed to quantitatively measure IgG antibodies to SARS-CoV-2 Spike (S) Receptor Binding Domain (RBD) in human serum or plasma and is intended to be used in the assessment of the immune response to the SARS-CoV-2 S protein.

These controls are intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analysis of SARS-CoV-2 antigen on the LUMIPULSE G System.

Particle-agglutination test for the detection of antibodies to Human T Lymphotropic Retrovirus type I (HTLV-I).